United Kingdom next generation sequencing market is expected to register robust growth in the forecast period, 2023-2027. Next Generation Sequencing (NGS) refers to a technology that is commonly utilized to determine the sequence of nucleotides in each DNA sample. It allows sequencing of DNA or RNA in a less time and at an affordable cost. The continuous technological advancements in sequencing procedures, increase in genome mapping programs, and rise in drug discovery platforms demanding NGS technology. Moreover, the elevating number of initiatives by government bodies for large-scale genomic sequencing projects and emergence of cloud computing as a potential data management service are driving the adoption of NGS products. Enhancing reimbursement and regulatory scenario for next generation sequencing based diagnostic tests is proving to be beneficial for the market growth. Favorable funding scenario for genomics research across the United Kingdom will provide lucrative growth opportunities to the leading market players. Development of cost-effective next generation sequencing services and products for researchers is expected to promote the overall market expansion in the forthcoming years.

Rise in Genome Mapping Programs is Projected to Catalyze the Market Growth

The decreasing cost of sequencing has allowed governments bodies across United Kingdom to involve genomic analysis as a significant part of disease diagnosis and personalized medicine. Various public genome research initiatives have been undertaken and enhancing focus on genomics health futures mission for the improvement of research & development activities. The extensive investments on R & D activities to expand access to new research capabilities, clinical trials, and technologies for betterment of healthcare sector which is acting as another growth-inducing factor. The increase in genome mapping programs and extensive research activities on personalized medicine has further augmented the

Extensive R&D activities for Developing Novel Next Generation Sequencing Technologies Fuels the Market Growth

The rising R&D activities for producing therapies used in the treatment of genetic disorders will inflate the need for next generation sequencing procedure over the analysis period. With this, the elevating investments in R&D activities and high number of studies related to treatment of genetic disorders among individuals is going to support the growth of the market. Government bodies of developed economies such as United Kingdom have launched numerous policies and initiated acts for encouraging scientists and researchers to find solutions for treating chronic and rare ailments. All these aforementioned factors are expected to drive the market towards growth over the forecast period.

Escalating Demand for DNA Testing is Estimated to Witness the Market Growth

The growing demand for DNA testing owing to the continuous advancements in whole genome and exome sequencing procedures, which offers faster results and cost effectives of the process as compared to genotyping-based DNA microarray. This made manufacturers to launch the first commercial sequencer, MinIon, utilizing Nanopore technology was introduced by Oxford Nanopore Technologies. The sequencer assists in identifying DNA by measuring the modifications in the electrical conductivity generated DNA strands passed through biological pore. This technology allowed the detection of outbreaks such as Zika virus. Various organizations worked on DNA sequencing technologies for applied genomic testing, by introducing GENIUS sequencer, which can sequence DNA anywhere.


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The United Kingdom next generation sequencing market is segmented into product, technology, application, end user, regional distribution, and competitive landscape. Based on product, the market is divided into consumables, platforms, services. Based on technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, single molecule real time sequencing, others. Based on application, the market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, agriculture & animal research, others. Based on end user, the market is segmented into academic & clinical research centers, pharmaceutical & biotechnology companies, hospitals & clinics, others. To analyze the market based on the region, the United Kingdom next generation sequencing market is studied in major regions namely London, Southeast, East Anglia, Scotland, Southwest, East Midlands, and Yorkshire & Humberside.

Market Players

Thermo Fischer Scientific, Inc., Illumina Cambridge Limited, PerkinElmer (UK) Limited, Agilent Technologies UK Limited, Qiagen Manchester Limited, Oxford Nanopore Technologies Limited, Roche Diagnostics Limited, are the significant market players operating in United Kingdom next generation sequencing market.

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Product

·         Technology

·         Application

·         End User

Regional scope

London, Southeast, East Anglia, Scotland, Southwest, East Midlands, and Yorkshire & Humberside

Key companies profiled

Thermo Fischer Scientific, Inc., Illumina Cambridge Limited, PerkinElmer (UK) Limited, Agilent Technologies UK Limited, Qiagen Manchester Limited, Oxford Nanopore Technologies Limited, Roche Diagnostics Limited

Customization scope

10% free report customization with purchase. Addition or alteration to regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, United Kingdom next generation sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·          United Kingdom Next Generation Sequencing Market, By Product:

o   Consumables

o   Platforms

o   Services

·         United Kingdom Next Generation Sequencing Market, By Technology:

o   Sequencing by Synthesis

o   Ion Semiconductor Sequencing

o   Sequencing by Ligation

o   Single Molecule Real Time Sequencing

o   Others

·         United Kingdom Next Generation Sequencing Market, By Application:

o   Biomarkers & Cancer

o   Diagnostics

o   Reproductive Health

o   Personalized Medicine

o   Agriculture & Animal Research

o   Others

·         United Kingdom Next Generation Sequencing Market, By End User:

o   Academic & Clinical Research Centers

o   Pharmaceutical & Biotechnology Companies

o   Hospitals & Clinics

o   Others

·          United Kingdom Next Generation Sequencing Market, By Region:

o   London

o   Southeast

o   East Anglia

o   Scotland

o   Southwest

o   East Midlands

o   Yorkshire & Humberside

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United Kingdom Next Generation Sequencing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

o   Detailed analysis and profiling of additional market players (up to five).

 United Kingdom next generation sequencing market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on United Kingdom Next Generation Sequencing Market

4.    Executive Summary

5.    Voice of Customer

6.    United Kingdom Next Generation Sequencing Market Outlook

6.1.  Market Size & Forecast

6.1.1. By Value

6.2.  Market Share & Forecast

6.2.1. By Product (Consumables, Platforms, Services)

6.2.2. By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing, Others)

6.2.3. By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, Others)

6.2.4. By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others)

6.2.5. By Region

6.2.6. By Company (2020)

6.3.  Product Market Map

7.    United Kingdom Next Generation Sequencing By Synthesis Market Outlook

7.1.  Market Size & Forecast          

7.1.1. By Value

7.2.  Market Share & Forecast

7.2.1. By Product

7.2.2. By Application

7.2.3. By End User

8.    United Kingdom Ion Semiconductor Sequencing Market Outlook

8.1.  Market Size & Forecast          

8.1.1. By Value

8.2.  Market Share & Forecast

8.2.1. By Product

8.2.2. By Application

8.2.3. By End User

9.    United Kingdom Sequencing By Ligation Market Outlook

9.1.  Market Size & Forecast          

9.1.1. By Value

9.2.  Market Share & Forecast

9.2.1. By Product

9.2.2. By Application

9.2.3. By End User

10.  United Kingdom Single Molecule Real Time Sequencing Market Outlook

10.1.              Market Size & Forecast

10.1.1.    By Value

10.2.              Market Share & Forecast

10.2.1.    By Product

10.2.2.    By Application

10.2.3.    By End User

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Policy & Regulatory Landscape

14.  United Kingdom Economic Profile

15.  Competitive Landscape

15.1.              Thermo Fischer Scientific, Inc.

15.2.              Illumina Cambridge Limited

15.3.              PerkinElmer (UK) Limited

15.4.              Agilent Technologies UK Limited

15.5.              Qiagen Manchester Limited

15.6.              Oxford Nanopore Technologies Limited

15.7.              Roche Diagnostics Limited

16.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com